- On-Demand
Advances in Non-Hodgkin Lymphoma Care: Navigating New and Emerging Treatments
- Credit: 0.25hr(s)
- AAPA, ABIM, CME, CPE, MOC, NCPD, Royal College MOC
- May 15, 2024 —
- May 14, 2025
- Therapeutic Areas: Pan Tumor, Pathology, Pharmacy
- Specialties: Pathology, Pharmacy
- Location: Internet Activity Enduring
In this first episode, “Making the Right Selection: Expert Guidance on Treatment Sequencing of T-cell Mediated Therapies,” from the 4-part series Med Table Talk, “The Power of the Community: Translating Innovations into Care in NHL and HL,” learn from expert faculty about unmet needs for patients with NHL based on an understanding of disease- and patient-related characteristics. Additionally, learn how to best assess eligible patients among new and emerging CAR T-cell and bispecific antibody therapies. Expert faculty will also discuss both the mechanisms of action of CAR T-cell and bispecific antibodies. This episode will conclude with a patient case study, which will consist of a dialogue between faculty.